Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGF βi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Gemcitabine; Procedure: Magnetic Resonance Imaging; Biological: Naxitamab; Biological: Universal Donor Expanded TGF-beta-imprinted NK Cells Sponsor: Margaret Gatti-Mays Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
Condition: Estrogen Receptor-Positive Breast Carcinoma Interventions: Dietary Supplement: Mushroom; Drug: Placebo Administration; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGF βi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Gemcitabine; Procedure: Magnetic Resonance Imaging; Biological: Naxitamab; Biological: Universal Donor Expanded TGF-beta-imprinted NK Cells Sponsor: Margaret Gatti-Mays Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
Condition: Estrogen Receptor-Positive Breast Carcinoma Interventions: Dietary Supplement: Mushroom; Drug: Placebo Administration; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGF βi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Gemcitabine; Procedure: Magnetic Resonance Imaging; Biological: Naxitamab; Biological: Universal Donor Expanded TGF-beta-imprinted NK Cells Sponsor: Margaret Gatti-Mays Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
Condition: Estrogen Receptor-Positive Breast Carcinoma Interventions: Dietary Supplement: Mushroom; Drug: Placebo Administration; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGF βi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Gemcitabine; Procedure: Magnetic Resonance Imaging; Biological: Naxitamab; Biological: Universal Donor Expanded TGF-beta-imprinted NK Cells Sponsor: Margaret Gatti-Mays Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
Condition: Estrogen Receptor-Positive Breast Carcinoma Interventions: Dietary Supplement: Mushroom; Drug: Placebo Administration; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Conditions: Breast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer; ER Positive Breast Cancer; HER2 Negative Breast Carcinoma Interventions: Drug: OP-1250; Drug: Fulvestrant; Drug: Anastrozole; Drug: Letrozole; Drug: Exemestane Sponsor: Olema Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials
